BioCentury | Dec 31, 2020
Deals

Dec. 30 Quick Takes: COVAXX-Aurobindo and Moderna-Recipharm in COVID deals; plus United-Y-mAbs, Zai-Cullinan and Incyte-Cellenkos

...DPI —a dry powder formulation of treprostinil...
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...FDA issued a complete response letter for an NDA for LIQ861, an inhalation powder formulation of treprostinil...
BioCentury | Apr 10, 2020
Product Development

April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge

...Liquidia Technologies Inc. (NASDAQ:LQDA) to treat pulmonary arterial hypertension. The inhaler-delivered dry powder formulation of treprostinil...
BioCentury | Sep 11, 2019
Company News

Sept. 11 Company Quick Takes: Glaxo to buy Sitari; plus Aimmune, Xeris, Puma and United Therapeutics

...PAH therapy Trevyent United Therapeutics Corp. (NASDAQ:UTHR) said FDA has accepted its NDA for Trevyent treprostinil...
...hypertension. The application has a PDUFA date of April 27, 2020. Trevyent combines the drug treprostinil...
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...Gene Therapies Ltd. (NASDAQ:AXGT) hired David Nassif as CFO. He was EVP and CFO of SteadyMed...
BioCentury | Apr 8, 2019
Clinical News

United Therapeutics' esuberaprost fails Phase III in PAH

...a prostacyclin analog. BEAT evaluated oral esuberaprost as an add-on to Tyvaso, the company's inhaled treprostinil...
...United Therapeutics Corp. (NASDAQ:UTHR) includes Tyvaso; Remodulin, which is a subcutaneous or IV version of treprostinil...
BioCentury | Mar 29, 2019
Company News

Sandoz launches first generic Remodulin in the U.S.

...launched in the U.S. the first generic version of pulmonary arterial hypertension (PAH) drug Remodulin treprostinil...
...treprostinil, a synthetic long-acting stable prostacyclin analog. United Therapeutics also markets an inhaled formulation of treprostinil...
BioCentury | Feb 22, 2019
Politics & Policy

China releases list of rare disease drugs with reduced VAT

...Johnson (NYSE:JNJ); Adempas riociguat from Bayer AG (Xetra:BAYN); Ventavis/Ilomedin iloprost from Actelion and Bayer; Remodulin treprostinil...
BioCentury | Sep 7, 2018
Company News

MannKind stock climbs after closing treprostinil deal with United Therapeutics

...on Sept. 4 after signing a deal with United Therapeutics Corp. (NASDAQ:UTHR) for rights to Treprostinil...
...double-digit royalties. United Therapeutics gains an exclusive, worldwide license to the dry powder formulation of treprostinil...
...Business: Cardiovascular Elizabeth S. Eaton Orenitram, oral treprostinil (UT-15C, treprostonil diethanolamine) Remodulin, Treprost, treprostinil (MD-0701, Uniprost, UT-15) Tyvaso, inhaled treprostinil...
BioCentury | Aug 17, 2018
Clinical News

United Therapeutics' Orenitram delays disease progression in Phase III for PAH

...United Therapeutics Corp. (NASDAQ:UTHR) said Orenitram treprostinil met the primary endpoint in the double-blind, international Phase...
...patients were not on any approved background therapy. Orenitram is a sustained-release oral formulation of treprostinil...
...Spring, Md. Product: Orenitram treprostinil Business: Cardiovascular Molecular target: NA Description: Sustained-release oral formulation of treprostinil...
Items per page:
1 - 10 of 276